Neutralising antibodies against interferon beta in multiple sclerosis.
Giovannoni
Gavin
G
Deisenhammer
Florian
F
D000906:Antibodies / Q000276:immunology*; D000917:Antibody Formation / Q000276:immunology; D015331:Cohort Studies; D018450:Disease Progression; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology* / Q000627:therapeutic use*; D016899:Interferon-beta / Q000276:immunology* / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology; D009500:Neutralization Tests / Q000706:statistics & numerical data; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D012107:Research Design / Q000592:standards; D016896:Treatment Outcome
D000906:Antibodies; D007155:Immunologic Factors; D016899:Interferon-beta